Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.502286554320327e-55,58.52320675105485,7338.152563240265,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.2398094402293958e-52,0,0,73
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.299705479559463e-37,29.748865674791602,2484.863168539067,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",9.38047869882025e-35,0,0,55
3,Oxidative phosphorylation WP623,4.256312839349877e-23,32.21533193836789,1659.4456993694632,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",5.022449150432855e-21,0,0,33
4,Nonalcoholic fatty liver disease WP4396,5.645979117811348e-21,9.039687924016283,421.460473601818,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'EIF2S1', 'COX6B1', 'NDUFS8', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'BAX', 'PPARA']",4.996691519263043e-19,0,0,47
5,Mitochondrial complex I assembly model OXPHOS system WP4324,8.163279222595972e-13,12.91294349540079,359.41835602809545,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3']",5.779601689597948e-11,0,0,23
6,Mitochondrial CIV Assembly WP4922,4.909374352265548e-09,11.875,227.19391700127125,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14', 'COX20']",2.8965308678366734e-07,0,0,16
7,Mitochondrial complex III assembly WP4921,2.7567267504250293e-05,13.234536082474227,138.9478253629281,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0013941160995006576,0,0,8
8,Cellular Proteostasis WP4918,0.003662455040332395,13.171794871794871,73.88878476531008,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.1440565649197409,0,0,4
9,Glycolysis in senescence WP5049,0.003662455040332395,13.171794871794871,73.88878476531008,"['LDHA', 'PKM', 'ALDOC', 'GAPDH']",0.1440565649197409,0,0,4
10,Synaptic Vesicle Pathway WP2267,0.007135348574060025,3.5216494845360824,17.406436394096836,"['SLC32A1', 'CLTC', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'CPLX3']",0.24575813687988857,0,0,8
11,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.007653547455348189,8.77948717948718,42.77880648454007,"['EIF3I', 'EIF2S1', 'EIF3D', 'EIF1']",0.24575813687988857,0,0,4
12,Glutathione metabolism WP100,0.008330784301013172,19.736235595390525,94.4931028663208,"['GPX4', 'IDH1', 'GSS']",0.24575813687988857,0,0,3
13,Proteasome Degradation WP183,0.010102102242513164,2.9723225806451614,13.657857135210142,"['PSMB6', 'PSMC5', 'PSMB5', 'UBB', 'H2AFZ', 'PSMC1', 'HLA-B', 'UBA1', 'PSMB10']",0.25663702570252717,0,0,9
14,Pyrimidine metabolism WP4022,0.01014948689219034,2.5975328035483276,11.923538279754492,"['POLE4', 'POLR3GL', 'POLD2', 'NME2', 'ENPP1', 'NME3', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.25663702570252717,0,0,11
15,Ferroptosis WP4313,0.011263321923414097,3.552321552321552,15.936438020351549,"['MAP1LC3A', 'GPX4', 'FTH1', 'GSS', 'SLC3A2', 'SAT2', 'FTL']",0.2658143973925727,0,0,7
16,Translation Factors WP107,0.0158519812034142,2.9329896907216493,12.155660768938162,"['EEF1B2', 'EIF2B5', 'EIF2AK1', 'EIF3I', 'EIF2B1', 'EIF2S1', 'EIF3D', 'EIF1']",0.35072508412553915,0,0,8
17,Glycolysis and Gluconeogenesis WP534,0.019563347139148392,3.0774774774774776,12.107096473167617,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'ALDOC', 'GAPDH']",0.36822680523311074,0,0,7
18,Amino Acid metabolism WP3925,0.01966558358794416,2.5831136044880787,10.148756802998763,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'RARS', 'IDH1', 'GSS', 'ODC1', 'SRM']",0.36822680523311074,0,0,9
19,7q11.23 copy number variation syndrome WP4932,0.019763585591607638,2.2033678756476682,8.645826376224958,"['ATP5F1A', 'ATP5F1B', 'CLTC', 'ATP5MC2', 'ATP5PO', 'SQSTM1', 'GAPDH', 'ATP5F1D', 'VPS28', 'CLASP1', 'ATP5F1E', 'ATP5MC1']",0.36822680523311074,0,0,12
20,Base Excision Repair WP4752,0.023922674187112893,3.294987146529563,12.299951620911813,"['POLE4', 'NEIL2', 'MPG', 'TDG', 'APEX1', 'POLD2']",0.4234313331118982,0,0,6
21,Cytosine methylation WP3585,0.04788048986393867,13.140664961636828,39.93510062768406,"['IDH1', 'TDG']",0.7903725129569812,0,0,2
22,Urea cycle and metabolism of amino groups WP497,0.05358457714962584,4.9311779769526245,14.431062723311657,"['ODC1', 'CKB', 'SRM']",0.7903725129569812,0,0,3
23,Cori Cycle WP1946,0.05358457714962584,4.9311779769526245,14.431062723311657,"['LDHA', 'PGAM1', 'GAPDH']",0.7903725129569812,0,0,3
24,Nanomaterial induced apoptosis WP2507,0.05358457714962584,4.9311779769526245,14.431062723311657,"['ENDOG', 'BAX', 'CYCS']",0.7903725129569812,0,0,3
25,Metabolic reprogramming in colon cancer WP4290,0.0734406540810034,2.3236050204143353,6.067577802347126,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'GAPDH', 'IDH3A']",0.9999271970377753,0,0,6
26,Computational Model of Aerobic Glycolysis WP4629,0.07750508619293311,3.9441741357234315,10.08687714653793,"['LDHA', 'PKM', 'GAPDH']",0.9999271970377753,0,0,3
27,Nucleotide metabolism WP404,0.07750508619293311,3.9441741357234315,10.08687714653793,"['NME2', 'OAZ1', 'SRM']",0.9999271970377753,0,0,3
28,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.08743025116124911,6.569053708439898,16.00821850925472,"['GSTP1', 'COX5A']",0.9999271970377753,0,0,2
29,Dual hijack model of Vif in HIV infection WP3300,0.08743025116124911,6.569053708439898,16.00821850925472,"['UBB', 'ELOB']",0.9999271970377753,0,0,2
30,Selenium Micronutrient Network WP15,0.0874581768869079,2.1940874035989717,5.346101471973874,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOK', 'SELENOH']",0.9999271970377753,0,0,6
31,Gastric Cancer Network 2 WP2363,0.10518791584019717,3.2861715749039693,7.400480909169134,"['OTUD5', 'S100A6', 'BRIX1']",0.9999271970377753,0,0,3
32,DNA Repair Pathways Full Network WP4946,0.11896744658264778,1.6934930875576037,3.605286547504827,"['POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'MPG', 'TDG', 'APEX1', 'POLD2', 'GTF2H5']",0.9999271970377753,0,0,9
33,Parkinson's disease pathway WP2371,0.12635451561182393,2.3906759906759905,4.945504656802251,"['UBB', 'CYCS', 'UBA1', 'PARK7']",0.9999271970377753,0,0,4
34,EV release from cardiac cells and their functional effects WP3297,0.13236509729612198,inf,inf,['RGS16'],0.9999271970377753,0,0,1
35,Nanomaterial-induced inflammasome activation WP3890,0.13236509729612198,inf,inf,['CTSB'],0.9999271970377753,0,0,1
36,Nanoparticle triggered regulated necrosis WP2513,0.13236509729612198,inf,inf,['FTL'],0.9999271970377753,0,0,1
37,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.13319637040851534,4.378516624040921,8.826786391254034,"['MAP1LC3A', 'WIPI1']",0.9999271970377753,0,0,2
38,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.13607984584590957,2.8161697457472106,5.616888473999004,"['H3F3B', 'BCL6', 'H2AFZ']",0.9999271970377753,0,0,3
39,CAMKK2  Pathway WP4874,0.1517669596149115,2.1910256410256412,4.130979671093231,"['FIS1', 'MAP1LC3A', 'SQSTM1', 'CALM2']",0.9999271970377753,0,0,4
40,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.15652724605195154,1.9338518462584007,3.586376958700687,"['PPP1R3F', 'MAP1LC3A', 'EIF2AK1', 'DDIT3', 'EIF2S1']",0.9999271970377753,0,0,5
41,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.16959443730274515,2.4636683738796417,4.371398535662477,"['NDUFA13', 'HSP90AA1', 'AAMP']",0.9999271970377753,0,0,3
42,mRNA Processing WP411,0.17613250221779245,1.4483570504527814,2.5150991222100942,"['LSM7', 'SF3A1', 'CELF1', 'SNRPG', 'SNRPB2', 'SNRPF', 'DNAJC8', 'HNRNPA1', 'SRSF7', 'PRPF8', 'SRSF9']",0.9999271970377753,0,0,11
43,GABA receptor Signaling WP4159,0.178913812635798,2.0220907297830375,3.479717021768778,"['GABBR1', 'SLC32A1', 'AP2S1', 'AP2M1']",0.9999271970377753,0,0,4
44,Wnt signaling in kidney disease WP4150,0.18284466016090445,3.2832480818414322,5.57862702471342,"['WNT2B', 'DVL3']",0.9999271970377753,0,0,2
45,HIF1A and PPARG regulation of glycolysis WP2456,0.18284466016090445,3.2832480818414322,5.57862702471342,"['LDHA', 'GAPDH']",0.9999271970377753,0,0,2
46,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.20514543316087286,2.1895006402048653,3.468248101731723,"['MDH2', 'IDH3G', 'IDH3A']",0.9999271970377753,0,0,3
47,Histone Modifications WP2369,0.20514543316087286,2.1895006402048653,3.468248101731723,"['SET', 'H3F3B', 'SETDB2']",0.9999271970377753,0,0,3
48,Cytosolic DNA-sensing pathway WP4655,0.20752432262612844,1.8772893772893773,2.9520501775148995,"['IRF3', 'POLR3GL', 'POLR2K', 'POLR2L']",0.9999271970377753,0,0,4
49,Alzheimer's disease WP2059,0.21992518300892758,1.5775835475578406,2.3891995913905726,"['ATP5MD', 'APH1A', 'CHP1', 'CYCS', 'GAPDH', 'CALM2']",0.9999271970377753,0,0,6
50,Cysteine and methionine catabolism WP4504,0.23454870208921905,2.626086956521739,3.8080677600769604,"['GOT1', 'GSS']",0.9999271970377753,0,0,2
51,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.23454870208921905,2.626086956521739,3.8080677600769604,"['GOT1', 'MDH2']",0.9999271970377753,0,0,2
52,Modulators of TCR signaling and T cell activation WP5072,0.23732189350922991,1.7517948717948717,2.5196728851400425,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9999271970377753,0,0,4
53,Regulation of Microtubule Cytoskeleton WP2038,0.23732189350922991,1.7517948717948717,2.5196728851400425,"['PARD6A', 'STMN1', 'MAPRE1', 'CLASP1']",0.9999271970377753,0,0,4
54,IL-18 signaling pathway WP4754,0.24062045102853272,1.2960146209173447,1.8462175127009863,"['TOMM40', 'USP5', 'CD81', 'RGS16', 'COX17', 'NDUFC1', 'RND2', 'NACA', 'TMSB4X', 'STMN1', 'CYCS', 'BAX', 'AARS']",0.9999271970377753,0,0,13
55,SARS-CoV-2 mitochondrial interactions WP5038,0.24216995651291484,1.970166453265045,2.7939235843292556,"['TOMM70', 'NDUFB9', 'IRF3']",0.9999271970377753,0,0,3
56,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.24722914281844183,6.561941251596424,9.169917008573899,['VIP'],0.9999271970377753,0,0,1
57,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.24722914281844183,6.561941251596424,9.169917008573899,['GSS'],0.9999271970377753,0,0,1
58,Gastric acid production WP2596,0.24722914281844183,6.561941251596424,9.169917008573899,['VIP'],0.9999271970377753,0,0,1
59,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.24722914281844183,6.561941251596424,9.169917008573899,['ELOB'],0.9999271970377753,0,0,1
60,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.24722914281844183,6.561941251596424,9.169917008573899,['BLVRB'],0.9999271970377753,0,0,1
61,Irinotecan pathway WP229,0.24722914281844183,6.561941251596424,9.169917008573899,['CES2'],0.9999271970377753,0,0,1
62,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.24722914281844183,6.561941251596424,9.169917008573899,['BAX'],0.9999271970377753,0,0,1
63,Peroxiredoxin 2 induced ovarian failure WP4873,0.24722914281844183,6.561941251596424,9.169917008573899,['BAX'],0.9999271970377753,0,0,1
64,"Phase I biotransformations, non P450 WP136",0.24722914281844183,6.561941251596424,9.169917008573899,['CES2'],0.9999271970377753,0,0,1
65,NRF2 pathway WP2884,0.2581350930004366,1.3838849701573521,1.8741569635896222,"['HSP90AA1', 'FTH1', 'GSTP1', 'BLVRB', 'SLC39A7', 'SQSTM1', 'CES2', 'FTL']",0.9999271970377753,0,0,8
66,Differentiation Pathway WP2848,0.28014387373716754,1.7907112094051916,2.278594011490115,"['WNT2B', 'KIT', 'FGF1']",0.9999271970377753,0,0,3
67,NO/cGMP/PKG mediated Neuroprotection WP4008,0.28014387373716754,1.7907112094051916,2.278594011490115,"['PDE3A', 'CYCS', 'CALM2']",0.9999271970377753,0,0,3
68,Type II interferon signaling (IFNG) WP619,0.28689657345832587,2.187979539641944,2.731984549192542,"['IFNGR2', 'HLA-B']",0.9999271970377753,0,0,2
69,Urea cycle and associated pathways WP4595,0.28689657345832587,2.187979539641944,2.731984549192542,"['GOT1', 'MDH2']",0.9999271970377753,0,0,2
70,Zinc homeostasis WP3529,0.28689657345832587,2.187979539641944,2.731984549192542,"['SLC30A3', 'SLC39A7']",0.9999271970377753,0,0,2
71,DNA Mismatch Repair WP531,0.28689657345832587,2.187979539641944,2.731984549192542,"['POLE4', 'POLD2']",0.9999271970377753,0,0,2
72,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.28689657345832587,2.187979539641944,2.731984549192542,"['CD63', 'CD81']",0.9999271970377753,0,0,2
73,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.28689657345832587,2.187979539641944,2.731984549192542,"['FGF1', 'GTPBP4']",0.9999271970377753,0,0,2
74,Hippo-Yap signaling pathway WP4537,0.28689657345832587,2.187979539641944,2.731984549192542,"['MAP4K2', 'TNIK']",0.9999271970377753,0,0,2
75,miRNA regulation of p53 pathway in prostate cancer WP3982,0.28689657345832587,2.187979539641944,2.731984549192542,"['SHISA5', 'BAX']",0.9999271970377753,0,0,2
76,Pregnane X receptor pathway WP2876,0.28689657345832587,2.187979539641944,2.731984549192542,"['HSP90AA1', 'PSMC5']",0.9999271970377753,0,0,2
77,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3048104060015155,1.1425395256916997,1.3574115818650385,"['YWHAE', 'RPL5', 'SET', 'CLTC', 'RPL10A', 'RPL7', 'SCUBE2', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'RPLP2', 'CCT7', 'HSP90AA1', 'TRPC3', 'RPS6', 'SARS', 'RPL13A', 'CYCS', 'RPL27', 'RPL26', 'ATP6V0D1', 'GAPDH', 'EIF3D', 'PTMA']",0.9999271970377753,0,0,25
78,Ciliary landscape WP4352,0.31614721800353535,1.2035585758389507,1.385954621328863,"['NDUFA5', 'SSNA1', 'VPS4A', 'COPS7A', 'MYL6B', 'COX6C', 'LSM4', 'MYL6', 'MFAP1', 'DVL3', 'SNRPB2', 'DCAF11', 'CALM2']",0.9999271970377753,0,0,13
79,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.31859120853454237,1.6411651728553136,1.8772409994067518,"['MAP1LC3A', 'WIPI1', 'FTL']",0.9999271970377753,0,0,3
80,Proximal tubule transport WP4917,0.3311335372194043,1.458974358974359,1.6125074090415727,"['ATP6V1A', 'ATP6V1G1', 'SLC3A2', 'ATP6V1F']",0.9999271970377753,0,0,4
81,16p11.2 distal deletion syndrome WP4950,0.33881332486905963,1.87504567044209,2.0293731557227614,"['CD81', 'SPNS1']",0.9999271970377753,0,0,2
82,Neural Crest Cell Migration during Development WP4564,0.33881332486905963,1.87504567044209,2.0293731557227614,"['CDH11', 'EPHB3']",0.9999271970377753,0,0,2
83,Apoptosis Modulation by HSP70 WP384,0.3469034500036749,3.2803320561941254,3.4729163486049877,['CYCS'],0.9999271970377753,0,0,1
84,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.3469034500036749,3.2803320561941254,3.4729163486049877,['PPARA'],0.9999271970377753,0,0,1
85,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.3469034500036749,3.2803320561941254,3.4729163486049877,['PPARA'],0.9999271970377753,0,0,1
86,Estrogen Receptor Pathway WP2881,0.3469034500036749,3.2803320561941254,3.4729163486049877,['PPARA'],0.9999271970377753,0,0,1
87,Homologous recombination WP186,0.3469034500036749,3.2803320561941254,3.4729163486049877,['POLD2'],0.9999271970377753,0,0,1
88,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.3469034500036749,3.2803320561941254,3.4729163486049877,['VEGFB'],0.9999271970377753,0,0,1
89,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.3469034500036749,3.2803320561941254,3.4729163486049877,['ECI1'],0.9999271970377753,0,0,1
90,Non-homologous end joining WP438,0.3469034500036749,3.2803320561941254,3.4729163486049877,['DCLRE1C'],0.9999271970377753,0,0,1
91,Osteoclast Signaling WP12,0.3469034500036749,3.2803320561941254,3.4729163486049877,['ATP6V1G1'],0.9999271970377753,0,0,1
92,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3570891042321913,1.514626218851571,1.5597165454481017,"['LDHA', 'PKM', 'BAX']",0.9999271970377753,0,0,3
93,Eukaryotic Transcription Initiation WP405,0.3630338833861241,1.3819163292847503,1.4002393049471378,"['TAF13', 'TAF6', 'POLR2I', 'POLR2K']",0.9999271970377753,0,0,4
94,TP53 network WP1742,0.38949668102562185,1.6403452685421995,1.546681446795425,"['SUMO1', 'BAX']",0.9999271970377753,0,0,2
95,Neural Crest Cell Migration in Cancer WP4565,0.38949668102562185,1.6403452685421995,1.546681446795425,"['CDH11', 'EPHB3']",0.9999271970377753,0,0,2
96,PKC-gamma calcium signaling pathway in ataxia WP4760,0.38949668102562185,1.6403452685421995,1.546681446795425,"['PRKCG', 'TRPC3']",0.9999271970377753,0,0,2
97,Ebola Virus Pathway on Host WP4217,0.414304871192393,1.1932694554802523,1.0514531661322455,"['IRF3', 'CLTC', 'VPS4A', 'HLA-B', 'EIF2S1', 'CTSB']",0.9999271970377753,0,0,6
98,Acute viral myocarditis WP4298,0.4264419133940387,1.2498168498168498,1.0651927986852217,"['ENDOG', 'CYCS', 'BAX', 'DMD']",0.9999271970377753,0,0,4
99,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.4328185379107721,1.3121638924455825,1.0988542260032736,"['DLG1', 'CHP1', 'CALM2']",0.9999271970377753,0,0,3
100,ACE Inhibitor Pathway WP554,0.43339448284315046,2.186462324393359,1.8281162795322103,['ATP6AP2'],0.9999271970377753,0,0,1
101,Aspirin and miRNAs WP4707,0.43339448284315046,2.186462324393359,1.8281162795322103,['PPARA'],0.9999271970377753,0,0,1
102,TCA cycle in senescence WP5050,0.43339448284315046,2.186462324393359,1.8281162795322103,['GOT1'],0.9999271970377753,0,0,1
103,Biomarkers for urea cycle disorders WP4583,0.43339448284315046,2.186462324393359,1.8281162795322103,['GOT1'],0.9999271970377753,0,0,1
104,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.43339448284315046,2.186462324393359,1.8281162795322103,['GABBR1'],0.9999271970377753,0,0,1
105,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.43339448284315046,2.186462324393359,1.8281162795322103,['SQSTM1'],0.9999271970377753,0,0,1
106,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.4383638281138705,1.4578005115089514,1.2022569097225861,"['IDH1', 'IDH3A']",0.9999271970377753,0,0,2
107,White fat cell differentiation WP4149,0.4383638281138705,1.4578005115089514,1.2022569097225861,"['IRF3', 'DDIT3']",0.9999271970377753,0,0,2
108,Fluoropyrimidine Activity WP1601,0.4383638281138705,1.4578005115089514,1.2022569097225861,"['TDG', 'CES2']",0.9999271970377753,0,0,2
109,Methionine De Novo and Salvage Pathway WP3580,0.4383638281138705,1.4578005115089514,1.2022569097225861,"['ODC1', 'SRM']",0.9999271970377753,0,0,2
110,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.46947414317864955,1.2299135723431498,0.9299893760052936,"['OTUD5', 'IRF3', 'PIN1']",0.9999271970377753,0,0,3
111,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.4850074853553453,1.311764705882353,0.9491810755319423,"['LDHA', 'RPS6']",0.9999271970377753,0,0,2
112,Notch Signaling WP268,0.4850074853553453,1.311764705882353,0.9491810755319423,"['APH1A', 'DVL3']",0.9999271970377753,0,0,2
113,Nucleotide Excision Repair WP4753,0.5050227894775873,1.157339760488062,0.79063865152777,"['POLE4', 'POLD2', 'GTF2H5']",0.9999271970377753,0,0,3
114,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5084439701487924,1.6395274584929758,1.1089767928008858,['IFNGR2'],0.9999271970377753,0,0,1
115,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5084439701487924,1.6395274584929758,1.1089767928008858,['IRF3'],0.9999271970377753,0,0,1
116,Biomarkers for pyrimidine metabolism disorders WP4584,0.5084439701487924,1.6395274584929758,1.1089767928008858,['CKB'],0.9999271970377753,0,0,1
117,Trans-sulfuration pathway WP2333,0.5084439701487924,1.6395274584929758,1.1089767928008858,['GOT1'],0.9999271970377753,0,0,1
118,Transcriptional cascade regulating adipogenesis WP4211,0.5084439701487924,1.6395274584929758,1.1089767928008858,['DDIT3'],0.9999271970377753,0,0,1
119,"Cerebral organic acidurias, including diseases WP4519",0.5084439701487924,1.6395274584929758,1.1089767928008858,['MDH2'],0.9999271970377753,0,0,1
120,Genes targeted by miRNAs in adipocytes WP1992,0.5084439701487924,1.6395274584929758,1.1089767928008858,['TMSB4X'],0.9999271970377753,0,0,1
121,Heart Development WP1591,0.5084439701487924,1.6395274584929758,1.1089767928008858,['VEGFB'],0.9999271970377753,0,0,1
122,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5084439701487924,1.6395274584929758,1.1089767928008858,['RPS6'],0.9999271970377753,0,0,1
123,Insulin signaling in adipocytes (normal condition) WP3634,0.5084439701487924,1.6395274584929758,1.1089767928008858,['RPS6'],0.9999271970377753,0,0,1
124,Iron metabolism in placenta WP2007,0.5084439701487924,1.6395274584929758,1.1089767928008858,['FTH1'],0.9999271970377753,0,0,1
125,Matrix Metalloproteinases WP129,0.5084439701487924,1.6395274584929758,1.1089767928008858,['MMP16'],0.9999271970377753,0,0,1
126,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5084439701487924,1.6395274584929758,1.1089767928008858,['COL5A1'],0.9999271970377753,0,0,1
127,Mitochondrial fatty acid synthesis pathway WP4317,0.5084439701487924,1.6395274584929758,1.1089767928008858,['HSD17B12'],0.9999271970377753,0,0,1
128,Nanoparticle triggered autophagic cell death WP2509,0.5084439701487924,1.6395274584929758,1.1089767928008858,['MAP1LC3A'],0.9999271970377753,0,0,1
129,Overview of interferons-mediated signaling pathway WP4558,0.5084439701487924,1.6395274584929758,1.1089767928008858,['IFNGR2'],0.9999271970377753,0,0,1
130,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5084439701487924,1.6395274584929758,1.1089767928008858,['IRF3'],0.9999271970377753,0,0,1
131,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5211818428770125,1.0432022932022933,0.6798093167970399,"['YWHAE', 'SST', 'ATP1A3', 'SSTR2', 'NGF', 'GAPDH', 'SLC25A4']",0.9999271970377753,0,0,7
132,Allograft Rejection WP2328,0.5291597385159298,1.192280864915136,0.7588449566770382,"['COL5A1', 'HLA-B']",0.9999271970377753,0,0,2
133,DNA Replication WP466,0.5291597385159298,1.192280864915136,0.7588449566770382,"['POLD2', 'UBA52']",0.9999271970377753,0,0,2
134,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5392954112625933,1.0928297055057619,0.6748133659546321,"['STMN1', 'BAX', 'ANGPTL1']",0.9999271970377753,0,0,3
135,Amyotrophic lateral sclerosis (ALS) WP2447,0.5706623555705017,1.0927109974424551,0.612964500885471,"['TOMM40', 'BAX']",0.9999271970377753,0,0,2
136,Unfolded protein response WP4925,0.5706623555705017,1.0927109974424551,0.612964500885471,"['DDIT3', 'EIF2S1']",0.9999271970377753,0,0,2
137,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.572163054723043,1.0351101826268616,0.5779343802887089,"['BEX3', 'RNF7', 'SQSTM1']",0.9999271970377753,0,0,3
138,Exercise-induced Circadian Regulation WP410,0.572163054723043,1.0351101826268616,0.5779343802887089,"['DAZAP2', 'SUMO1', 'GSTP1']",0.9999271970377753,0,0,3
139,Serotonin and anxiety-related events WP3944,0.5735637874200623,1.3113665389527458,0.7289704622227475,['CRH'],0.9999271970377753,0,0,1
140,Thiamine metabolic pathways WP4297,0.5735637874200623,1.3113665389527458,0.7289704622227475,['BCKDK'],0.9999271970377753,0,0,1
141,Complement and Coagulation Cascades WP558,0.5735637874200623,1.3113665389527458,0.7289704622227475,['CLTC'],0.9999271970377753,0,0,1
142,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5735637874200623,1.3113665389527458,0.7289704622227475,['H3F3B'],0.9999271970377753,0,0,1
143,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5735637874200623,1.3113665389527458,0.7289704622227475,['ENPP1'],0.9999271970377753,0,0,1
144,Overview of nanoparticle effects WP3287,0.5735637874200623,1.3113665389527458,0.7289704622227475,['BAX'],0.9999271970377753,0,0,1
145,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5735637874200623,1.3113665389527458,0.7289704622227475,['LDHA'],0.9999271970377753,0,0,1
146,PPAR-alpha pathway WP2878,0.5735637874200623,1.3113665389527458,0.7289704622227475,['PPARA'],0.9999271970377753,0,0,1
147,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5735637874200623,1.3113665389527458,0.7289704622227475,['ANAPC11'],0.9999271970377753,0,0,1
148,SARS coronavirus and innate immunity WP4912,0.5735637874200623,1.3113665389527458,0.7289704622227475,['IRF3'],0.9999271970377753,0,0,1
149,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5749327098045659,1.0084812623274162,0.558196669422826,"['PRKCG', 'RPS6', 'PDGFC', 'BAX']",0.9999271970377753,0,0,4
150,Nuclear Receptors Meta-Pathway WP2882,0.6005406641292689,0.9586124099582964,0.488820358986804,"['PSMC5', 'HSP90AA1', 'FTH1', 'GSTP1', 'BLVRB', 'BAX', 'SERPINB9', 'SLC39A7', 'PPARA', 'SQSTM1', 'CES2', 'FTL']",0.9999271970377753,0,0,12
151,Aryl Hydrocarbon Receptor Pathway WP2873,0.6094425028028131,1.0084595711194178,0.49939993941275934,"['HSP90AA1', 'BAX']",0.9999271970377753,0,0,2
152,Complement system WP2806,0.6094425028028131,1.0084595711194178,0.49939993941275934,"['RPS19', 'CD59']",0.9999271970377753,0,0,2
153,Copper homeostasis WP3286,0.6094425028028131,1.0084595711194178,0.49939993941275934,"['COX17', 'ATOX1']",0.9999271970377753,0,0,2
154,G13 Signaling Pathway WP524,0.6094425028028131,1.0084595711194178,0.49939993941275934,"['ARHGDIG', 'CALM2']",0.9999271970377753,0,0,2
155,Genotoxicity pathway WP4286,0.6094425028028131,1.0084595711194178,0.49939993941275934,"['RPS27', 'PHLDA3']",0.9999271970377753,0,0,2
156,Glycogen Synthesis and Degradation WP500,0.6094425028028131,1.0084595711194178,0.49939993941275934,"['PHKG1', 'CALM2']",0.9999271970377753,0,0,2
157,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.6094425028028131,1.0084595711194178,0.49939993941275934,"['HSP90AA1', 'BAX']",0.9999271970377753,0,0,2
158,Pathways in clear cell renal cell carcinoma WP4018,0.6255060916376664,0.93599853291766,0.43916509248807356,"['LDHA', 'PKM', 'ALDOC', 'GAPDH', 'SQSTM1']",0.9999271970377753,0,0,5
159,Signal Transduction of S1P Receptor WP26,0.6300662545867904,1.0925925925925926,0.5047016231074983,['ASAH1'],0.9999271970377753,0,0,1
160,Alanine and aspartate metabolism WP106,0.6300662545867904,1.0925925925925926,0.5047016231074983,['GOT1'],0.9999271970377753,0,0,1
161,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.6300662545867904,1.0925925925925926,0.5047016231074983,['SST'],0.9999271970377753,0,0,1
162,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6300662545867904,1.0925925925925926,0.5047016231074983,['IRF3'],0.9999271970377753,0,0,1
163,Type II diabetes mellitus WP1584,0.6300662545867904,1.0925925925925926,0.5047016231074983,['SURF1'],0.9999271970377753,0,0,1
164,Ebstein-Barr virus LMP1 signaling WP262,0.6300662545867904,1.0925925925925926,0.5047016231074983,['HSP90AA1'],0.9999271970377753,0,0,1
165,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6300662545867904,1.0925925925925926,0.5047016231074983,['BAX'],0.9999271970377753,0,0,1
166,Immune response to tuberculosis WP4197,0.6300662545867904,1.0925925925925926,0.5047016231074983,['IFNGR2'],0.9999271970377753,0,0,1
167,Kynurenine Pathway and links to Cellular Senescence WP5044,0.6300662545867904,1.0925925925925926,0.5047016231074983,['EIF2AK1'],0.9999271970377753,0,0,1
168,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.6300662545867904,1.0925925925925926,0.5047016231074983,['PPARA'],0.9999271970377753,0,0,1
169,Oxidative Stress WP408,0.6300662545867904,1.0925925925925926,0.5047016231074983,['TXN2'],0.9999271970377753,0,0,1
170,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6300662545867904,1.0925925925925926,0.5047016231074983,['BAX'],0.9999271970377753,0,0,1
171,Wnt signaling pathway and pluripotency WP399,0.6333413932835364,0.9361624291201756,0.4275881418521518,"['PRKCG', 'WNT2B', 'DVL3']",0.9999271970377753,0,0,3
172,Apoptosis WP254,0.6615549341775592,0.8934349901059248,0.3691336143245715,"['IRF3', 'CYCS', 'BAX']",0.9999271970377753,0,0,3
173,Wnt Signaling Pathway WP363,0.6788560512564089,0.8736572890025576,0.33840780915074775,"['PRKCG', 'DVL3']",0.9999271970377753,0,0,2
174,Energy Metabolism WP1541,0.6788560512564089,0.8736572890025576,0.33840780915074775,"['PPRC1', 'PPARA']",0.9999271970377753,0,0,2
175,Serotonin and anxiety WP3947,0.6790904460993049,0.936325488049626,0.36235885847368104,['CRH'],0.9999271970377753,0,0,1
176,Sleep regulation WP3591,0.6790904460993049,0.936325488049626,0.36235885847368104,['CRH'],0.9999271970377753,0,0,1
177,Airway smooth muscle cell contraction WP4962,0.6790904460993049,0.936325488049626,0.36235885847368104,['CALM2'],0.9999271970377753,0,0,1
178,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6790904460993049,0.936325488049626,0.36235885847368104,['CALM2'],0.9999271970377753,0,0,1
179,Cell migration and invasion through p75NTR WP4561,0.6790904460993049,0.936325488049626,0.36235885847368104,['CDH11'],0.9999271970377753,0,0,1
180,Constitutive Androstane Receptor Pathway WP2875,0.6790904460993049,0.936325488049626,0.36235885847368104,['HSP90AA1'],0.9999271970377753,0,0,1
181,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6790904460993049,0.936325488049626,0.36235885847368104,['RPS6'],0.9999271970377753,0,0,1
182,Melatonin metabolism and effects WP3298,0.6790904460993049,0.936325488049626,0.36235885847368104,['CALM2'],0.9999271970377753,0,0,1
183,Mitochondrial Gene Expression WP391,0.6790904460993049,0.936325488049626,0.36235885847368104,['PPRC1'],0.9999271970377753,0,0,1
184,MTHFR deficiency WP4288,0.6790904460993049,0.936325488049626,0.36235885847368104,['CYCS'],0.9999271970377753,0,0,1
185,Prostaglandin Synthesis and Regulation WP98,0.6790904460993049,0.936325488049626,0.36235885847368104,['S100A6'],0.9999271970377753,0,0,1
186,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6790904460993049,0.936325488049626,0.36235885847368104,['BAX'],0.9999271970377753,0,0,1
187,Non-small cell lung cancer WP4255,0.6881609820717395,0.854422980571174,0.3193256219327559,"['PRKCG', 'CYCS', 'BAX']",0.9999271970377753,0,0,3
188,Adipogenesis WP236,0.6902373072573618,0.861597189379096,0.31941115233779205,"['CELF1', 'DDIT3', 'MIF', 'PPARA', 'ZMPSTE24']",0.9999271970377753,0,0,5
189,Common Pathways Underlying Drug Addiction WP2636,0.7096107070826082,0.8188938618925832,0.2809123343015821,"['PRKCG', 'CALM2']",0.9999271970377753,0,0,2
190,Development of ureteric collection system WP5053,0.7096107070826082,0.8188938618925832,0.2809123343015821,"['ROBO2', 'GDF11']",0.9999271970377753,0,0,2
191,Kit receptor signaling pathway WP304,0.7096107070826082,0.8188938618925832,0.2809123343015821,"['RPS6', 'KIT']",0.9999271970377753,0,0,2
192,One-carbon metabolism and related pathways WP3940,0.7096107070826082,0.8188938618925832,0.2809123343015821,"['GPX4', 'GSS']",0.9999271970377753,0,0,2
193,Sphingolipid Metabolism (general overview) WP4725,0.7216250364790603,0.8191251596424011,0.2672392680109152,['ASAH1'],0.9999271970377753,0,0,1
194,Sphingolipid Metabolism (integrated pathway) WP4726,0.7216250364790603,0.8191251596424011,0.2672392680109152,['ASAH1'],0.9999271970377753,0,0,1
195,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.7216250364790603,0.8191251596424011,0.2672392680109152,['PPARA'],0.9999271970377753,0,0,1
196,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7216250364790603,0.8191251596424011,0.2672392680109152,['RPS6'],0.9999271970377753,0,0,1
197,Toll-like Receptor Signaling related to MyD88 WP3858,0.7216250364790603,0.8191251596424011,0.2672392680109152,['IRF3'],0.9999271970377753,0,0,1
198,GDNF/RET signaling axis WP4830,0.7216250364790603,0.8191251596424011,0.2672392680109152,['ROBO2'],0.9999271970377753,0,0,1
199,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7216250364790603,0.8191251596424011,0.2672392680109152,['B3GALT2'],0.9999271970377753,0,0,1
200,Nanoparticle-mediated activation of receptor signaling WP2643,0.7216250364790603,0.8191251596424011,0.2672392680109152,['TLN1'],0.9999271970377753,0,0,1
201,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7216250364790603,0.8191251596424011,0.2672392680109152,['OMG'],0.9999271970377753,0,0,1
202,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7216250364790603,0.8191251596424011,0.2672392680109152,['GSTP1'],0.9999271970377753,0,0,1
203,Physiological and pathological hypertrophy of the heart WP1528,0.7216250364790603,0.8191251596424011,0.2672392680109152,['CALM2'],0.9999271970377753,0,0,1
204,Breast cancer pathway WP4262,0.7289224318913812,0.818196405648267,0.25870384917057737,"['WNT2B', 'KIT', 'DVL3', 'BAX', 'FGF1']",0.9999271970377753,0,0,5
205,MAPK Signaling Pathway WP382,0.7357309861410165,0.8409400921658986,0.2580767229994346,"['PRKCG', 'DUSP4', 'MAP4K2', 'DUSP3', 'DDIT3', 'STMN1', 'FGF1', 'RASGRP2', 'NGF']",0.9999271970377753,0,0,9
206,Apoptosis Modulation and Signaling WP1772,0.7365958406246427,0.7857618437900128,0.24021990631804493,"['ENDOG', 'CYCS', 'BAX']",0.9999271970377753,0,0,3
207,TNF-alpha signaling pathway WP231,0.7365958406246427,0.7857618437900128,0.24021990631804493,"['MAP4K2', 'HSP90AA1', 'BAX']",0.9999271970377753,0,0,3
208,Glucocorticoid Receptor Pathway WP2880,0.7378620332036478,0.7705731909131939,0.23425303155868635,"['HSP90AA1', 'SERPINB9']",0.9999271970377753,0,0,2
209,Rett syndrome causing genes WP4312,0.7378620332036478,0.7705731909131939,0.23425303155868635,"['IMPDH2', 'GPS2']",0.9999271970377753,0,0,2
210,DNA damage response (only ATM dependent) WP710,0.7407560082198458,0.7934731934731934,0.23810859516328686,"['WNT2B', 'BCL6', 'DVL3', 'BAX']",0.9999271970377753,0,0,4
211,Regulation of toll-like receptor signaling pathway WP1449,0.7407560082198458,0.7934731934731934,0.23810859516328686,"['OTUD5', 'IRF3', 'SQSTM1', 'RNF41']",0.9999271970377753,0,0,4
212,MECP2 and Associated Rett Syndrome WP3584,0.7584843013227548,0.7553924948291145,0.20881554753830292,"['BCL6', 'SST', 'RPS6']",0.9999271970377753,0,0,3
213,Melanoma WP4685,0.7584843013227548,0.7553924948291145,0.20881554753830292,"['KIT', 'BAX', 'CALM2']",0.9999271970377753,0,0,3
214,Striated Muscle Contraction Pathway WP383,0.7585281365114399,0.7279693486590039,0.2011928096897792,['DMD'],0.9999271970377753,0,0,1
215,TLR4 Signaling and Tolerance WP3851,0.7585281365114399,0.7279693486590039,0.2011928096897792,['IRF3'],0.9999271970377753,0,0,1
216,Canonical and non-canonical Notch signaling WP3845,0.7585281365114399,0.7279693486590039,0.2011928096897792,['MFAP1'],0.9999271970377753,0,0,1
217,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7585281365114399,0.7279693486590039,0.2011928096897792,['PPIB'],0.9999271970377753,0,0,1
218,Endothelin Pathways WP2197,0.7585281365114399,0.7279693486590039,0.2011928096897792,['CALM2'],0.9999271970377753,0,0,1
219,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7585281365114399,0.7279693486590039,0.2011928096897792,['DDIT3'],0.9999271970377753,0,0,1
220,Imatinib and Chronic Myeloid Leukemia WP3640,0.7585281365114399,0.7279693486590039,0.2011928096897792,['KIT'],0.9999271970377753,0,0,1
221,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7585281365114399,0.7279693486590039,0.2011928096897792,['MAP4K2'],0.9999271970377753,0,0,1
222,miRNA targets in ECM and membrane receptors WP2911,0.7585281365114399,0.7279693486590039,0.2011928096897792,['COL5A1'],0.9999271970377753,0,0,1
223,"GPCRs, Other WP117",0.7637330251931813,0.7276214833759591,0.19612090765337797,"['SSTR2', 'CELSR2']",0.9999271970377753,0,0,2
224,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7637330251931813,0.7276214833759591,0.19612090765337797,"['IFNGR2', 'STMN1']",0.9999271970377753,0,0,2
225,EGF/EGFR signaling pathway WP437,0.7639941784942141,0.7789290298918027,0.2096838855852899,"['NDUFA13', 'STMN1', 'AP2S1', 'NEDD8', 'AP2M1']",0.9999271970377753,0,0,5
226,Wnt signaling WP428,0.7788788944050301,0.7272727272727273,0.18174524224850575,"['PRKCG', 'WNT2B', 'DVL3']",0.9999271970377753,0,0,3
227,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7873580014626372,0.6891910082110647,0.16476643822023287,"['WNT2B', 'DVL3']",0.9999271970377753,0,0,2
228,BDNF-TrkB Signaling WP3676,0.7905445162177914,0.6550446998722861,0.15395732395469114,['TRPC3'],0.9999271970377753,0,0,1
229,Trans-sulfuration and one-carbon metabolism WP2525,0.7905445162177914,0.6550446998722861,0.15395732395469114,['GSS'],0.9999271970377753,0,0,1
230,Tumor suppressor activity of SMARCB1 WP4204,0.7905445162177914,0.6550446998722861,0.15395732395469114,['H3F3B'],0.9999271970377753,0,0,1
231,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7905445162177914,0.6550446998722861,0.15395732395469114,['CYCS'],0.9999271970377753,0,0,1
232,Fatty acid beta-oxidation WP143,0.7905445162177914,0.6550446998722861,0.15395732395469114,['ECI1'],0.9999271970377753,0,0,1
233,Glycosylation and related congenital defects WP4521,0.7905445162177914,0.6550446998722861,0.15395732395469114,['DPM2'],0.9999271970377753,0,0,1
234,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.7905445162177914,0.6550446998722861,0.15395732395469114,['IRF3'],0.9999271970377753,0,0,1
235,Metapathway biotransformation Phase I and II WP702,0.7948425037264044,0.7269230769230769,0.16690974722158358,"['GPX4', 'GSTO1', 'GSTP1', 'GSS']",0.9999271970377753,0,0,4
236,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8088774599429251,0.6546035805626599,0.1388465544220274,"['PRKCG', 'IFI27L2']",0.9999271970377753,0,0,2
237,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8100028109144396,0.7265725288831836,0.15310159121723296,"['DLG1', 'RPS6', 'NGF', 'SQSTM1', 'EIF2S1']",0.9999271970377753,0,0,5
238,16p11.2 proximal deletion syndrome WP4949,0.8154110597661465,0.6768510751026535,0.13812021022949392,"['TMEM219', 'SEZ6L2', 'CCT7']",0.9999271970377753,0,0,3
239,Spinal Cord Injury WP2431,0.8154110597661465,0.6768510751026535,0.13812021022949392,"['APEX1', 'OMG', 'MIF']",0.9999271970377753,0,0,3
240,Sphingolipid pathway WP1422,0.8183205584724024,0.5953790781376989,0.11937418292918142,['ASAH1'],0.9999271970377753,0,0,1
241,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8183205584724024,0.5953790781376989,0.11937418292918142,['IRF3'],0.9999271970377753,0,0,1
242,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.8183205584724024,0.5953790781376989,0.11937418292918142,['RABAC1'],0.9999271970377753,0,0,1
243,Netrin-UNC5B signaling pathway WP4747,0.8183205584724024,0.5953790781376989,0.11937418292918142,['DAPK1'],0.9999271970377753,0,0,1
244,Oxidative Damage WP3941,0.8183205584724024,0.5953790781376989,0.11937418292918142,['CYCS'],0.9999271970377753,0,0,1
245,Pre-implantation embryo WP3527,0.8183205584724024,0.5953790781376989,0.11937418292918142,['DDIT3'],0.9999271970377753,0,0,1
246,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8284340949795382,0.6233101936426745,0.1173181934638158,"['CYCS', 'BAX']",0.9999271970377753,0,0,2
247,DNA damage response WP707,0.8284340949795382,0.6233101936426745,0.1173181934638158,"['CYCS', 'BAX']",0.9999271970377753,0,0,2
248,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8284340949795382,0.6233101936426745,0.1173181934638158,"['DCLRE1C', 'BAX']",0.9999271970377753,0,0,2
249,Endometrial cancer WP4155,0.8284340949795382,0.6233101936426745,0.1173181934638158,"['BAX', 'FGF1']",0.9999271970377753,0,0,2
250,Prolactin Signaling Pathway WP2037,0.8284340949795382,0.6233101936426745,0.1173181934638158,"['RPS6', 'PPIB']",0.9999271970377753,0,0,2
251,Osteoblast differentiation WP4787,0.8316740294043008,0.6541613316261203,0.12057155385060704,"['PRKCG', 'WNT2B', 'FGF1']",0.9999271970377753,0,0,3
252,Fragile X Syndrome  WP4549,0.8364998825177138,0.6953814218993254,0.12414567963696393,"['DUSP3', 'ALDH5A1', 'CLTC', 'AP2S1', 'AP2M1']",0.9999271970377753,0,0,5
253,Splicing factor NOVA regulated synaptic proteins WP4148,0.8424172417801041,0.5456577266922095,0.09356930562737777,['CLASP1'],0.9999271970377753,0,0,1
254,Bladder cancer WP2828,0.8424172417801041,0.5456577266922095,0.09356930562737777,['DAPK1'],0.9999271970377753,0,0,1
255,Cardiac Progenitor Differentiation WP2406,0.8424172417801041,0.5456577266922095,0.09356930562737777,['KIT'],0.9999271970377753,0,0,1
256,Type 2 papillary renal cell carcinoma WP4241,0.8424172417801041,0.5456577266922095,0.09356930562737777,['ELOB'],0.9999271970377753,0,0,1
257,Genes controlling nephrogenesis WP4823,0.8424172417801041,0.5456577266922095,0.09356930562737777,['ROBO2'],0.9999271970377753,0,0,1
258,IL-2 signaling pathway WP49,0.8424172417801041,0.5456577266922095,0.09356930562737777,['RPS6'],0.9999271970377753,0,0,1
259,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8424172417801041,0.5456577266922095,0.09356930562737777,['NELFE'],0.9999271970377753,0,0,1
260,Nuclear receptors WP170,0.8424172417801041,0.5456577266922095,0.09356930562737777,['PPARA'],0.9999271970377753,0,0,1
261,Peptide GPCRs WP24,0.8424172417801041,0.5456577266922095,0.09356930562737777,['SSTR2'],0.9999271970377753,0,0,1
262,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8424172417801041,0.5456577266922095,0.09356930562737777,['IRF3'],0.9999271970377753,0,0,1
263,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8461697583453757,0.5948616600790514,0.09936288366865466,"['APEX1', 'RPS6']",0.9999271970377753,0,0,2
264,miRNA regulation of DNA damage response WP1530,0.8461697583453757,0.5948616600790514,0.09936288366865466,"['CYCS', 'BAX']",0.9999271970377753,0,0,2
265,ESC Pluripotency Pathways WP3931,0.8466906636380299,0.6329354425674281,0.10533303100690022,"['WNT2B', 'DVL3', 'FGF1']",0.9999271970377753,0,0,3
266,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8466906636380299,0.6329354425674281,0.10533303100690022,"['PSMC5', 'PSMC1', 'UBA1']",0.9999271970377753,0,0,3
267,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8622231844417887,0.5688869120426999,0.08433243707086122,"['RPS6', 'ZNF516']",0.9999271970377753,0,0,2
268,The influence of laminopathies on Wnt signaling WP4844,0.8633214122731856,0.5035858139306415,0.07401111130993451,['ZMPSTE24'],0.9999271970377753,0,0,1
269,Folate Metabolism WP176,0.8633214122731856,0.5035858139306415,0.07401111130993451,['GPX4'],0.9999271970377753,0,0,1
270,Integrated Cancer Pathway WP1971,0.8633214122731856,0.5035858139306415,0.07401111130993451,['BAX'],0.9999271970377753,0,0,1
271,Interleukin-11 Signaling Pathway WP2332,0.8633214122731856,0.5035858139306415,0.07401111130993451,['RPS6'],0.9999271970377753,0,0,1
272,Lung fibrosis WP3624,0.8633214122731856,0.5035858139306415,0.07401111130993451,['FGF1'],0.9999271970377753,0,0,1
273,Neovascularisation processes WP4331,0.8633214122731856,0.5035858139306415,0.07401111130993451,['KIT'],0.9999271970377753,0,0,1
274,Pathways Regulating Hippo Signaling WP4540,0.8732608650139082,0.5943429170061693,0.08054591871746611,"['PRKCG', 'KIT', 'CDH11']",0.9999271970377753,0,0,3
275,22q11.2 copy number variation syndrome WP4657,0.8767283310601365,0.545076726342711,0.071709261382483,"['RANBP1', 'MRPL40']",0.9999271970377753,0,0,2
276,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8767283310601365,0.545076726342711,0.071709261382483,"['WNT2B', 'DVL3']",0.9999271970377753,0,0,2
277,Vitamin D-sensitive calcium signaling in depression WP4698,0.8814555686255184,0.46752417442072614,0.05899251950549464,['GPX4'],0.9999271970377753,0,0,1
278,IL-5 signaling pathway WP127,0.8814555686255184,0.46752417442072614,0.05899251950549464,['RPS6'],0.9999271970377753,0,0,1
279,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8814555686255184,0.46752417442072614,0.05899251950549464,['PRKCG'],0.9999271970377753,0,0,1
280,Prader-Willi and Angelman Syndrome WP3998,0.8814555686255184,0.46752417442072614,0.05899251950549464,['NGF'],0.9999271970377753,0,0,1
281,Corticotropin-releasing hormone signaling pathway WP2355,0.889813213200903,0.5231713554987212,0.06107696557706612,"['HSP90AA1', 'CRH']",0.9999271970377753,0,0,2
282,Joubert Syndrome WP4656,0.889813213200903,0.5231713554987212,0.06107696557706612,"['CEP120', 'DVL3']",0.9999271970377753,0,0,2
283,Retinoblastoma gene in cancer WP2446,0.889813213200903,0.5231713554987212,0.06107696557706612,"['H2AFZ', 'STMN1']",0.9999271970377753,0,0,2
284,Myometrial relaxation and contraction pathways WP289,0.8944834745471005,0.6419992414345316,0.07158859757429548,"['PRKCG', 'YWHAE', 'GSTO1', 'RGS16', 'CRH', 'CALM2']",0.9999271970377753,0,0,6
285,Senescence and Autophagy in Cancer WP615,0.8956721262589074,0.5601609657947686,0.06171901890506746,"['GABARAPL1', 'MAP1LC3A', 'SQSTM1']",0.9999271970377753,0,0,3
286,Aryl Hydrocarbon Receptor Netpath WP2586,0.8971863583751899,0.43627075351213285,0.047331747470264904,['HSP90AA1'],0.9999271970377753,0,0,1
287,Disruption of postsynaptic signaling by CNV WP4875,0.8971863583751899,0.43627075351213285,0.047331747470264904,['DLG1'],0.9999271970377753,0,0,1
288,Pathogenic Escherichia coli infection WP2272,0.8971863583751899,0.43627075351213285,0.047331747470264904,['ARPC3'],0.9999271970377753,0,0,1
289,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9015991283013919,0.5029510131811922,0.05209832308189709,"['EIF2B5', 'CALM2']",0.9999271970377753,0,0,2
290,Circadian rhythm related genes WP3594,0.906372112035549,0.6044073598630724,0.059416469544373705,"['PRKCG', 'CRH', 'PPARA', 'RPS27A', 'UBA52']",0.9999271970377753,0,0,5
291,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9108319520917395,0.40892401021711366,0.038192220193080745,['BANF1'],0.9999271970377753,0,0,1
292,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9108319520917395,0.40892401021711366,0.038192220193080745,['MAP1LC3A'],0.9999271970377753,0,0,1
293,IL-6 signaling pathway WP364,0.9108319520917395,0.40892401021711366,0.038192220193080745,['VIP'],0.9999271970377753,0,0,1
294,p53 transcriptional gene network WP4963,0.9108319520917395,0.40892401021711366,0.038192220193080745,['BAX'],0.9999271970377753,0,0,1
295,Photodynamic therapy-induced unfolded protein response WP3613,0.9108319520917395,0.40892401021711366,0.038192220193080745,['DDIT3'],0.9999271970377753,0,0,1
296,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9108319520917395,0.40892401021711366,0.038192220193080745,['CALM2'],0.9999271970377753,0,0,1
297,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9122001901657278,0.484228473998295,0.04449856602012515,"['ENPP1', 'CALM2']",0.9999271970377753,0,0,2
298,Endochondral Ossification WP474,0.9122001901657278,0.484228473998295,0.04449856602012515,"['ENPP1', 'CALM2']",0.9999271970377753,0,0,2
299,Leptin signaling pathway WP2034,0.9122001901657278,0.484228473998295,0.04449856602012515,"['RPS6', 'BAX']",0.9999271970377753,0,0,2
300,Integrated breast cancer pathway WP1984,0.9203671273518852,0.5555919258046917,0.04610448313778012,"['FER', 'ODC1', 'BAX', 'FAU']",0.9999271970377753,0,0,4
301,Vitamin D Receptor Pathway WP2877,0.9226463023351437,0.5156344767167599,0.04151338228777774,"['BCL6', 'S100A6', 'CLPTM1L']",0.9999271970377753,0,0,3
302,ATM Signaling Network in Development and Disease  WP3878,0.9226684460798863,0.3847945308391556,0.03097031185686057,['DCLRE1C'],0.9999271970377753,0,0,1
303,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9226684460798863,0.3847945308391556,0.03097031185686057,['ZMPSTE24'],0.9999271970377753,0,0,1
304,Interferon type I signaling pathways WP585,0.9226684460798863,0.3847945308391556,0.03097031185686057,['RPS6'],0.9999271970377753,0,0,1
305,p38 MAPK Signaling Pathway WP400,0.9226684460798863,0.3847945308391556,0.03097031185686057,['DDIT3'],0.9999271970377753,0,0,1
306,Hepatitis B infection WP4666,0.9273560397224246,0.5439102564102564,0.04102046586684108,"['PRKCG', 'IRF3', 'CYCS', 'BAX']",0.9999271970377753,0,0,4
307,Endoderm differentiation WP2853,0.9301126808972905,0.5023145868216291,0.03639245970531976,"['DUSP4', 'TCEAL2', 'NME1']",0.9999271970377753,0,0,3
308,Nephrotic syndrome WP4758,0.9329354198663312,0.36334610472541506,0.025223231612426823,['ZMPSTE24'],0.9999271970377753,0,0,1
309,Notch Signaling Pathway Netpath WP61,0.9329354198663312,0.36334610472541506,0.025223231612426823,['APH1A'],0.9999271970377753,0,0,1
310,Phosphodiesterases in neuronal function WP4222,0.9329354198663312,0.36334610472541506,0.025223231612426823,['PDE3A'],0.9999271970377753,0,0,1
311,PPAR signaling pathway WP3942,0.9329354198663312,0.36334610472541506,0.025223231612426823,['PPARA'],0.9999271970377753,0,0,1
312,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.93654973622703,0.6300936524453694,0.04130430859257247,"['HSP90AA1', 'COL5A1', 'PIK3IP1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'FGF1', 'NGF']",0.9999271970377753,0,0,9
313,B Cell Receptor Signaling Pathway WP23,0.9379241606955171,0.43554987212276214,0.027912729847790623,"['BCL6', 'CD81']",0.9999271970377753,0,0,2
314,Ectoderm Differentiation WP2858,0.9396989087608191,0.521948717948718,0.03246299972903128,"['ARHGDIG', 'DMD', 'MZF1', 'CELSR2']",0.9999271970377753,0,0,4
315,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9418407608044903,0.34415540767627884,0.020621469357227053,['TMSB4X'],0.9999271970377753,0,0,1
316,Cardiac Hypertrophic Response WP2795,0.9418407608044903,0.34415540767627884,0.020621469357227053,['CALM2'],0.9999271970377753,0,0,1
317,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9418407608044903,0.34415540767627884,0.020621469357227053,['RPS6'],0.9999271970377753,0,0,1
318,MET in type 1 papillary renal cell carcinoma WP4205,0.9418407608044903,0.34415540767627884,0.020621469357227053,['RPL11'],0.9999271970377753,0,0,1
319,RANKL/RANK signaling pathway WP2018,0.9418407608044903,0.34415540767627884,0.020621469357227053,['SQSTM1'],0.9999271970377753,0,0,1
320,Calcium Regulation in the Cardiac Cell WP536,0.9486429560161828,0.5343125907531724,0.028170446760990252,"['PRKCG', 'YWHAE', 'RGS16', 'ATP1B2', 'CALM2']",0.9999271970377753,0,0,5
321,Regulation of Actin Cytoskeleton WP51,0.9487114823429377,0.46616059996341686,0.02454361170484007,"['TMSB4X', 'BRK1', 'FGF1']",0.9999271970377753,0,0,3
322,Small cell lung cancer WP4658,0.9509094580241518,0.40816815856777494,0.020545727164090682,"['CYCS', 'BAX']",0.9999271970377753,0,0,2
323,Thermogenesis WP4321,0.9509094580241518,0.40816815856777494,0.020545727164090682,"['RPS6', 'ZNF516']",0.9999271970377753,0,0,2
324,IL-1 signaling pathway WP195,0.9562642046574262,0.31125706987775953,0.013919739688023574,['SQSTM1'],0.9999271970377753,0,0,1
325,G Protein Signaling Pathways WP35,0.9563869758399244,0.39572192513368987,0.017646293812572683,"['PRKCG', 'CALM2']",0.9999271970377753,0,0,2
326,AGE/RAGE pathway WP2324,0.9620746188165035,0.29705096946476256,0.011484960347127204,['CYCS'],0.9999271970377753,0,0,1
327,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9620746188165035,0.29705096946476256,0.011484960347127204,['TLN1'],0.9999271970377753,0,0,1
328,Ras signaling WP4223,0.9626523660277968,0.474032634032634,0.018043067640211307,"['PRKCG', 'KIT', 'RASGRP2', 'CALM2']",0.9999271970377753,0,0,4
329,Androgen receptor signaling pathway WP138,0.9656380681744224,0.3729630982827914,0.013041096917658477,"['SUMO1', 'PARK7']",0.9999271970377753,0,0,2
330,Toll-like Receptor Signaling Pathway WP75,0.9671139162592189,0.28408018213115666,0.00949935342720772,['IRF3'],0.9999271970377753,0,0,1
331,Neural Crest Differentiation WP2064,0.9671139162592189,0.28408018213115666,0.00949935342720772,['DVL3'],0.9999271970377753,0,0,1
332,Oncostatin M Signaling Pathway WP2374,0.9671139162592189,0.28408018213115666,0.00949935342720772,['RPS6'],0.9999271970377753,0,0,1
333,"GPCRs, Class A Rhodopsin-like WP455",0.9695250329267793,0.3625319693094629,0.011219996183719421,"['SSTR2', 'MCHR1']",0.9999271970377753,0,0,2
334,Hippo-Merlin Signaling Dysregulation WP4541,0.9695250329267793,0.3625319693094629,0.011219996183719421,"['KIT', 'CDH11']",0.9999271970377753,0,0,2
335,3q29 copy number variation syndrome WP4906,0.9714843201941052,0.27219029374201786,0.007874506049581611,['DLG1'],0.9999271970377753,0,0,1
336,TGF-beta Signaling Pathway WP366,0.9729865869604293,0.3526646851455036,0.009657716101377844,"['PARD6A', 'SUMO1']",0.9999271970377753,0,0,2
337,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9752745175894258,0.2612515964240102,0.006540771021522242,['DMD'],0.9999271970377753,0,0,1
338,ErbB signaling pathway WP673,0.9752745175894258,0.2612515964240102,0.006540771021522242,['PRKCG'],0.9999271970377753,0,0,1
339,Insulin Signaling WP481,0.9782179605756289,0.3909603072983355,0.008610029006303099,"['MAP4K2', 'ENPP1', 'STX4']",0.9999271970377753,0,0,3
340,Head and Neck Squamous Cell Carcinoma WP4674,0.9785614497423689,0.25115433736123394,0.005442939990453757,['RPS6'],0.9999271970377753,0,0,1
341,Cell cycle WP179,0.9788065708453897,0.33444816053511706,0.0071642923985541975,"['YWHAE', 'ANAPC11']",0.9999271970377753,0,0,2
342,Focal Adhesion WP306,0.9794521658439188,0.42690205968894496,0.008863288510807572,"['PRKCG', 'PDGFC', 'VEGFB', 'TLN1']",0.9999271970377753,0,0,4
343,PI3K-Akt signaling pathway WP4172,0.9795640588767021,0.5054054054054054,0.010435430971474079,"['HSP90AA1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'FGF1', 'NGF']",0.9999271970377753,0,0,7
344,Gastrin signaling pathway WP4659,0.9812412356534433,0.3260230179028133,0.006173878897083466,"['RPS6', 'KIT']",0.9999271970377753,0,0,2
345,DNA IR-damage and cellular response via ATR WP4016,0.987885731654744,0.21749680715197955,0.0026509041858609264,['BCL6'],0.9999271970377753,0,0,1
346,Glioblastoma signaling pathways WP2261,0.987885731654744,0.21749680715197955,0.0026509041858609264,['PRKCG'],0.9999271970377753,0,0,1
347,Pancreatic adenocarcinoma pathway WP4263,0.987885731654744,0.21749680715197955,0.0026509041858609264,['BAX'],0.9999271970377753,0,0,1
348,Integrin-mediated Cell Adhesion WP185,0.9908947738708686,0.20382343550447,0.001864359115745153,['TLN1'],0.9999271970377753,0,0,1
349,Genes related to primary cilium development (based on CRISPR) WP4536,0.9948574691845268,0.1810344827586207,0.0009333774296319487,['CEP120'],0.9999271970377753,0,0,1
350,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9961356350636319,0.17143913423405258,0.000663786763847895,['MAP4K2'],0.9999271970377753,0,0,1
351,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.99748292580483,0.1588013581285238,0.00040021870235789936,['WNT2B'],0.9999271970377753,0,0,1
352,Mesodermal commitment pathway WP2857,0.99748292580483,0.1588013581285238,0.00040021870235789936,['RPL38'],0.9999271970377753,0,0,1
353,Chemokine signaling pathway WP3929,0.9983605289741757,0.14788691512829444,0.00024265527999844347,['RASGRP2'],0.9999271970377753,0,0,1
354,Ciliopathies WP4803,0.9999271970377753,0.09816556368280506,7.14700398925046e-06,['CEP120'],0.9999271970377753,0,0,1
